Company name CymaBay Therapeutics, Inc.
Stock symbol CBAY
Status Under Investigation

NEW YORK, March 3, 2020 –Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CymaBay Therapeutics, Inc. (NASDAQ: CBAY) on behalf of CymaBay stockholders. Our investigation concerns whether CymaBay has violated the federal securities laws and/or engaged in other unlawful business practices.

On January 29, 2020, CymaBay announced in a letter from its President and CEO, that it had been “working to assess all potential ways to maximize value for our shareholders, including liquidation, sale, merger, asset acquisitions, and/or continuing development of our internal programs.”

On this news, CymaBay stock dropped $0.21 per share, or over 11%, to close at $1.65 on January 30, 2020.

If you purchased or otherwise acquired CymaBay shares, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact  Melissa Fortunato or Marion Passmore or by email at, telephone at (212) 355-4648, or by filling out the contact form below. There is no cost or obligation to you.


First name*

Last name*

City, state, ZIP code

Email address*

Daytime phone

Evening phone

Purchase Date

No. of Shares

Purchase Price

Purchase Date

No. of Shares

Purchase Price

Join action?

Call to provide more information: Tel: (212) 355-4648

Please list below any additional transactions in this security:

Additional comments

The submission of this form does not create an attorney-client relationship, nor any obligation on the part of Bragar Eagel & Squire, P.C., or you to file a legal action. Any information you submit will be maintained as confidential. If Bragar Eagel & Squire, P.C., in its sole discretion, believes that you might be an appropriate class representative, Bragar Eagel & Squire, P.C., will contact you to discuss the matter and to determine whether to establish an attorney client relationship.